Companies: 10,795·Total market cap: $144.5T
MetLife, Inc.

MetLife, Inc.

METNYSEFinancial Services● Active
$84.39
$-0.10(-0.12%)
Market Cap$54.3B
P/E Ratio
52W High$85.29
52W Low$67.33
Overview

MetLife, Inc. (MET) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

met · stock forecast · 33 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 33 Wall Street analysts in the past 3 months

SellBuy

Buy

33 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
25
Hold
8
Sell
0
Strong Sell
0
Total: 33 · Buy rate: 75.8%

12-Month Price Target

High

$102

Consensus

$94.29

+11.6% upside

Low

$86.00

Median: $95 · Last Close: $84.49

The MetLife, Inc. (MET) analyst consensus is Buy, based on ratings from 33 Wall Street analysts over the past 3 months. The average 12-month MET price target is $94.29, representing +11.6% upside from the current price of $84.49.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $94 (11.6%)

Consensus Target

$94.29

11.6% upside

High Target

$102

20.7%

Low Target

$86

1.8%

Current Price

$84.49

as of today

Based on analyst price targets, the MET stock price prediction for the next 12 months ranges from $86 to $102. The consensus MET price forecast of $94.29 implies 11.6% upside from the current price of $84.49.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$85.531.23%

1-day model range: $85.33–$85.73. Peak: $85.73 (+1.23%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$127+50.0%
2028$168+98.8%
2029$203+140.8%
2030$231+173.8%
2031+198.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)65.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MET · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$82.71BUY
MA 10$82.88BUY
MA 20$81.49BUY
MA 50$77.93BUY
MA 100$76.28BUY
MA 200$77.92BUY
Current $MET · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$83.16BUY
EMA 10$82.67BUY
EMA 20$81.65BUY
EMA 50$79.13BUY
EMA 100$77.82BUY
EMA 200$77.66BUY
Current $MET · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Piper Sandler2026-05-26
Maintains
NeutralNeutral
Morgan Stanley2026-05-21
Maintains
OverweightOverweight
Keefe, Bruyette & Woods2026-05-13
Maintains
OutperformOutperform
JP Morgan2026-05-12
Maintains
OverweightOverweight
Wells Fargo2026-05-12
Maintains
OverweightOverweight
Barclays2026-05-07
Maintains
OverweightOverweight
B of A Securities2026-04-14
Maintains
BuyBuy
Mizuho2026-04-13
Maintains
OutperformOutperform
Wells Fargo2026-04-10
Maintains
OverweightOverweight
UBS2026-04-09
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on MetLife, Inc. (MET) stock. Of the recent 280 rating actions, 24 were upgrades and 19 were downgrades. 33 analysts currently cover MET.

Analyst Recommendation Trends

Buy ratings15↑ +4
Hold ratings01↑ +1
Sell ratings00

MET analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 5 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$83.1B

↓ 0.9% YoY

Revenue Next Year

$80.4B

↓ 3.2% YoY

EPS This Year

$8.69

EPS Next Year

$9.90

↑ 14.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MET EPS of $8.69 for the current fiscal year, based on estimates from 10 analysts. The MET revenue forecast is $83.1B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The MET stock forecast is supported by two independent data sources: analyst consensus ratings from 33 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MET price target is $94.29 (+11.6% upside), with an analyst consensus of Buy.

The MET short-term stock prediction for tomorrow is $85.53 (+1.23%). The MET stock price prediction for 2027 estimates an average of $127. The MET stock prediction for 2030 projects a range of $225–$237.

MetLife, Inc. trades on NYSE under the ticker MET. The MET stock outlook for 2027 is broadly positive, supported by a Buy consensus among 76% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

MET forecast · 8 questions

According to 33 Wall Street analysts, the average 12-month MET price target is $94.29, with a high forecast of $102.00 and a low of $86.00. The median price target is shown in the chart above when available. This implies +11.6% potential upside from the current price of $84.49.

MET price targetWhat is MET price targetMET analyst price targetMET 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.